Isolation of a novel species in the genus Cupriavidus from a patient with sepsis using whole genome sequencing

Oh Joo Kweon,Yong Kwan Lim,Hye Ryoun Kim,Tae-Hyoung Kim,Sung-min Ha,Mi-Kyung Lee
DOI: https://doi.org/10.1371/journal.pone.0232850
IF: 3.7
2020-05-13
PLoS ONE
Abstract:Whole genome sequencing (WGS) has become an accessible tool in clinical microbiology, and it allowed us to identify a novel <em>Cupriavidus</em> species. We isolated Gram-negative bacillus from the blood of an immunocompromised patient, and phenotypical and molecular identifications were performed. Phenotypic identification discrepancies were noted between the Vitek 2 (bioMérieux, Marcy-l'Étoile, France) and Vitek MS systems (bioMérieux). Using 16S rRNA gene sequencing, it was impossible to identify the pathogen to the species levels. WGS was performed using the Illumina MiSeq platform (Illumina, San Diego, CA), and genomic sequence database searching with a TrueBac<sup>TM</sup> ID-Genome system (ChunLab, Inc., Seoul, Republic of Korea) showed no strains with average nucleotide identity values higher than 95.0%, which is the cut-off for species-level identification. Phylogenetic analysis indicated that the bacteria was a new <em>Cupriavidus</em> species that formed a subcluster with <em>Cupriavidus gilardii</em>. WGS holds great promise for accurate molecular identification beyond 16S rRNA gene sequencing in clinical microbiology.
multidisciplinary sciences
What problem does this paper attempt to address?